Hepatic delivery of particulates in the submicron range by a hydrodynamics-based procedure: Implications for particulate gene delivery systems

Journal of Gene Medicine

Volumn 6, Issue 4, 2004, Pages 455-463

  Kobayashi, Naoki ^a   Hirata, Kazuhiro ^a   Chen, Shi ^a   Kawase, Atsushi ^a   Nishikawa, Makiya ^a   Takakura, Yoshinobu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Hepatocyte; Hydrodynamics based procedure; Liver; Microsphere; Particle size; Plasmid DNA

Indexed keywords

GADOLINIUM CHLORIDE; MICROSPHERE; PLASMID DNA; POLYSTYRENE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLUOROMETRY; FROZEN SECTION; HYDRODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; LIVER; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ANIMALS; CELL CULTURE TECHNIQUES; CHEMISTRY, PHYSICAL; FEMALE; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; GADOLINIUM; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; HEPATOCYTES; KUPFFER CELLS; LIVER; MICE; MICE, INBRED STRAINS; MICROSPHERES; PARTICLE SIZE; POLYSTYRENES; SUSPENSIONS; TISSUE DISTRIBUTION; TRANSGENES;

EID: 4644228432     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.531     Document Type: Article

References (34)

1. Liu F, Song Y, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 1999; 6: 1258-1266.
2. Zhang G, Budker V, Wolff JA. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther 1999; 10: 1735-1737.
3. Song YK, Liu F, Zhang G, et al. Hydrodynamics-based transfection: simple and efficient method for introducing and expressing transgenes in animals by intravenous injection of DNA. Methods Enzymol 2002; 346: 92-105.
4. Maruyama H, Higuchi N, Nishikawa Y, et al. High-level expression of naked DNA delivered to rat liver via tail vein injection. J Gene Med 2002; 4: 333-341.
5. Kobayashi N, Kuramoto T, Yamaoka K, et al. Hepatic uptake and gene expression mechanisms following intravenous administration of plasmid DNA by conventional and hydrodynamics-based procedures. J Pharmacol Exp Ther 2001; 297: 853-860.
6. Kobayashi N, Kuramoto T, Chen S, et al. Therapeutic effect of intravenous interferon gene delivery with naked plasmid DNA in murine metastasis models. Mol Ther 2002; 6: 737-744.
7. Herweijer H, Zhang G, Subbotin VM, et al. Time course of gene expression after plasmid DNA gene transfer to the liver. J Gene Med 2001; 3: 280-291.
8. Budker V, Budker T, Zhang G, et al. Hypothesis: naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process. J Gene Med 2000; 2: 76-88.
9. Rossmanith W, Chabicovsky M, Herkner K, et al. Cellular gene dose and kinetics of gene expression in mouse livers transfected by high-volume tail-vein injection of naked DNA. DNA Cell Biol 2002; 21: 847-853.
10. Lecocq M, Andrianaivo F, Warnier MT, et al. Uptake by mouse liver and intracellular fate of plasmid DNA after a rapid tail vein injection of a small or a large volume. J Gene Med 2003; 5: 142-156.
11. Zhang G, Budker V, Williams P, et al. Surgical procedures for intravascular delivery of plasmid DNA to organs. Methods Enzymol 2002; 346: 125-133.
12. Zhang G, Vargo D, Budker V, et al. Expression of naked plasmid DNA injected into the afferent and efferent vessels of rodent and dog livers. Hum Gene Ther 1997; 8: 1763-1772.
13. Eastman SJ, Baskin KM, Hodges BL, et al. Development of catheter-based procedures for transducing the isolated rabbit liver with plasmid DNA. Hum Gene Ther 2002; 13: 2065-2077.
14. Wang Z, Qiu SJ, Ye SL, et al. Combined IL-12 and GM-CSF gene therapy for murine hepatocellular carcinoma. Cancer Gene Ther 2001; 8: 751-758.
15. Wu X, He Y, Falo LD Jr, et al. Regression of human mammary adenocarcinoma by systemic administration of a recombinant gene encoding the hFlex-TRAIL fusion protein. Mol Ther 2001; 3: 368-374.
16. Yang J, Chen S, Huang L, et al. Sustained expression of naked plasmid DNA encoding hepatocyte growth factor in mice promotes liver and overall body growth. Hepatology 2001; 33: 848-859.
17. Loser P, Jennings GS, Strauss M, et al. Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaB. J Virol 1998; 72: 180-190.
18. Mazda O. Improvement of nonviral gene therapy by Epstein-Barr virus (EBV)-based plasmid vectors. Curr Gene Ther 2002; 2: 379-392.
19. Yew NS, Zhao H, Przybylska M, et al. CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo. Mol Ther 2002; 5: 731-738.
20. Godbey WT, Wu KK, Mikos AG. Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc Natl Acad Sci U S A 1999; 96: 5177-5181.
21. Wang J, Zhang PC, Mao HQ, et al. Enhanced gene expression in mouse muscle by sustained release of plasmid DNA using PPE-EA as a carrier. Gene Ther 2002; 9: 1254-1261.
22. Kobayashi N, Nishikawa M, Hirata, et al. Hydrodynamics-based procedure involves transient hyperpermeability in the hepatic cellular membrane: implication of a nonspecific process in efficient intracellular gene delivery. J Gene Med; in press.
23. Ogawara K, Yoshida M, Higaki K, et al. Hepatic uptake of polystyrene microspheres in rats: effect of particle size on intrahepatic distribution. J Control Release 1999; 59: 15-22.
24. Ogawara K, Furumoto K, Takakura Y, et al. Surface hydrophobicity of particles is not necessarily the most important determinant in their in vivo disposition after intravenous administration in rats. J Control Release 2001; 77: 191-198.
25. Hardonk MJ, Dijkhuis FW, Hulstaert CE, et al. Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and repopulation. J Leukoc Biol 1992; 52: 296-302.
26. Nishikawa M, Takemura S, Takakura Y, et al. Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(L-lysine) complexes by controlling their physicochemical properties. J Pharmacol Exp Ther 1998; 287: 408-415.
27. Nishikawa M, Huang L. Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum Gene Ther 2001; 12: 861-870.
28. Davis ME. Non-viral gene delivery systems. Curr Opin Biotechnol 2002; 13: 128-131.
29. Niidome T, Huang L. Gene therapy progress and prospects: nonviral vectors. Gene Ther 2002; 9: 1647-1652.
30. Pouton CW, Seymour LW. Key issues in non-viral gene delivery. Adv Drug Deliv Rev 1998; 34: 3-19.
31. Moghimi SM, Davis SS. Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection. Crit Rev Ther Drug Carrier Syst 1994; 11: 31-59.
32. Illum L, Davis SS. The organ uptake of intravenously administered colloidal particles can be altered using a non-ionic surfactant (Poloxamer 338). FEBS Lett 1984; 167: 79-82.
33. Nishikawa M, Yamauchi M, Morimoto K, et al. Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system. Gene Ther 2000; 7: 548-555.
34. Hammermann M, Brun N, Klenin KV, et al. Salt-dependent DNA superhelix diameter studied by small angle neutron scattering measurements and Monte Carlo simulations. Biophys J 1998; 75: 3057-3063.